Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kimber

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|April 1, 1984
An analysis of resistance times to infection under treatmentH Kimber, M Crowder
Cardiovascular Research|May 1, 1981
Does beta-blockade directly reduce myocardial oxygen consumption?M Thomas, I T Gabe, H Kimber, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) studyAlex S F Doney, Jennifer Dannfald, Charlotte H Kimber, et al.
Diabetologia|April 13, 2007
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levelsC H Kimber, A S F Doney, E R Pearson, et al.
Diabetes|July 13, 2010
Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS studyColin N A Palmer, Charlotte H Kimber, Alex S F Doney, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Nature Genetics|July 3, 2007
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJulius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|April 1, 1984
An analysis of resistance times to infection under treatmentH Kimber, M Crowder
Cardiovascular Research|May 1, 1981
Does beta-blockade directly reduce myocardial oxygen consumption?M Thomas, I T Gabe, H Kimber, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) studyAlex S F Doney, Jennifer Dannfald, Charlotte H Kimber, et al.
Diabetologia|April 13, 2007
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levelsC H Kimber, A S F Doney, E R Pearson, et al.
Diabetes|July 13, 2010
Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS studyColin N A Palmer, Charlotte H Kimber, Alex S F Doney, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Nature Genetics|July 3, 2007
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJulius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir, et al.
Pageof 1